IDEAYA Biosciences, Inc. has grown revenue 73% a year over three years and 46% a year over five. Revenue growth, 3-year annual rate: +73% (Biotechnology median +17%). Revenue growth, 5-year rate: +46%, growth has picked up over the last three years. Years of annual history on file: 9, FY2017 to FY2025, as filed.

IDYAIDEAYA Biosciences, Inc.

Healthcare

$36.12+40% 1Y

$36.12

$25.6752 weeks$42.48

Is it growing?

Watch

Operating margin narrowing (−619.9 points). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 to watch, 2 without data

Margin direction−619.9 points operatingSEC EDGAR · Jun 30, 2026

Trailing-twelve-month operating margin, -963.2% now against -343.3% a year earlier.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is IDYA growing?

IDEAYA Biosciences, Inc. has grown revenue 73% a year over three years and 46% a year over five.

+73%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +46%
Revenue growth, 5-year rate · +73% over three · growth has picked up over the last three years
Years of annual history on file: 9
Years of annual history on file · FY2017 to FY2025, as filed

Details›